Pharma Pulse
search-icon

Tag: CGMP violations

FDA Warning Letters: Handling Manufacturing Violations and CGMP Compliance

FDA Warning Letters: Handling Manufacturing Violations and CGMP Compliance

Posted On August 30, 2026 11

Learn how to navigate FDA Warning Letters for manufacturing violations. Discover common CGMP triggers, response strategies, and the financial impact on pharmaceutical companies.

MOST POPULAR

First Generic Approval: Why It Matters for Drug Prices and Patient Access

First Generic Approval: Why It Matters for Drug Prices and Patient Access

Posted On May 17, 2026
Tibolone and Breast Cancer Risk: What Women Need to Know

Tibolone and Breast Cancer Risk: What Women Need to Know

Posted On September 23, 2025
Chemotherapy Drug Interactions and Safety Guide for Patients

Chemotherapy Drug Interactions and Safety Guide for Patients

Posted On March 31, 2026
FDA Authorization of Generics: Legal Basis and Approval Process Explained

FDA Authorization of Generics: Legal Basis and Approval Process Explained

Posted On July 24, 2026
Autoimmune Hepatitis: Understanding Immune-Mediated Liver Inflammation

Autoimmune Hepatitis: Understanding Immune-Mediated Liver Inflammation

Posted On August 18, 2026

Categories

  • Health (214)
  • Health Economics (18)

ARCHIVES

  • September 2026 (2)
  • August 2026 (12)
  • July 2026 (15)
  • June 2026 (12)
  • May 2026 (13)
  • April 2026 (7)
  • March 2026 (11)
  • February 2026 (11)
  • January 2026 (26)
  • December 2025 (29)
  • November 2025 (18)
  • October 2025 (30)
Pharma Pulse

Menu

  • About Pharma Pulse Weekly
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact Us

Recent Posts

First Generic Approval: Why It Matters for Drug Prices and Patient Access

First Generic Approval: Why It Matters for Drug Prices and Patient Access

Posted On May 17, 2026
Tibolone and Breast Cancer Risk: What Women Need to Know

Tibolone and Breast Cancer Risk: What Women Need to Know

Posted On September 23, 2025
© 2026. All rights reserved.